Recruiting
Phase 1

A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients with Hematological Malignancies

Sponsor:

Kahr Medical

Code:

NCT04937166

Conditions

Acute Myeloid Leukemia

Myelodysplastic Syndromes

Chronic Myelomonocytic Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DSP107

Azacitidine

Venetoclax

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information